Barinthus Biotherapeutics plc
BRNS
$0.74
-$0.02-2.49%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -10.58M | -5.53M | -11.09M | -14.57M | -21.12M |
| Total Depreciation and Amortization | 220.00K | 256.00K | 309.00K | 101.00K | 1.20M |
| Total Amortization of Deferred Charges | 600.00K | 600.00K | 600.00K | 800.00K | 800.00K |
| Total Other Non-Cash Items | 1.11M | -908.00K | 2.50M | 4.40M | 3.21M |
| Change in Net Operating Assets | 561.00K | 2.22M | 3.44M | -1.46M | -2.20M |
| Cash from Operations | -8.09M | -3.37M | -4.24M | -10.73M | -18.11M |
| Capital Expenditure | -- | -- | 0.00 | 0.00 | -32.00K |
| Sale of Property, Plant, and Equipment | 61.00K | 55.00K | 2.00K | 451.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 61.00K | 55.00K | 2.00K | 451.00K | -32.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 0.00 | 0.00 | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | 0.00 | 0.00 | 0.00 |
| Foreign Exchange rate Adjustments | 471.00K | -1.35M | 418.00K | -1.84M | 5.35M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.56M | -4.66M | -3.82M | -12.11M | -12.80M |